Founded by leading cardiovascular scientists, our team has the tenacity to pursue our ultimate peak – changing the treatment paradigm for heart disease, and in doing so improving and extending the lives of millions of individuals and families fighting this debilitating disease.

Learn More

We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease.

We are revolutionizing the treatment of heart disease through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.

Learn More

LATEST NEWS

Tenaya Therapeutics Unveils Preclinical Research Supporting Product Candidate for Rare and Prevalent Heart Disease Indications at ESC Heart Failure 2021
  • Highly specific HDAC6 inhibitors (HDAC6i) demonstrated improved cardiac function in mouse models of heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM)
  • Potential utility of HDAC6 as a target in heart disease was validated using Tenaya’s Precision Medicine platform
  • HDAC6i product candidate TYA-11631 is currently in IND-enabling studies

SOUTH SAN FRANCISCO,

Read More
Tenaya Therapeutics Announces New Appointments to Leadership Team
  • Gene therapy industry veteran Leone Patterson joins Tenaya as Chief Financial and Business Officer
  • Cardiologist Matthew Pollman appointed as Senior Vice President, Clinical Development

SOUTH SAN FRANCISCO,

Read More
Tenaya Therapeutics Receives Orphan Drug Designation and Presents Pre-Clinical Data for its Most Advanced Gene Therapy Product Candidate for Genetic Hypertrophic Cardiomyopathy
  • TN-201 is a potentially curative gene therapy intended to address genetic hypertrophic cardiomyopathy (gHCM) caused by mutations in the Myosin Binding Protein C3 (MYBPC3) gene,
Read More

Join Our Team

Are you ambitious, driven, energized by scientific innovation and committed to making a difference for patients suffering from heart disease? Do you value a culture grounded in science and collaboration? Our team combines deep biological insights, sophisticated drug development technologies and a boundless determination to change the future for the millions of people affected by heart disease.

Learn More